The University of Southampton
University of Southampton Institutional Repository

Blocking eukaryotic initiation factor 4F complex formation does not inhibit the mTORC1-dependent activation of protein synthesis in cardiomyocytes

Blocking eukaryotic initiation factor 4F complex formation does not inhibit the mTORC1-dependent activation of protein synthesis in cardiomyocytes
Blocking eukaryotic initiation factor 4F complex formation does not inhibit the mTORC1-dependent activation of protein synthesis in cardiomyocytes
Activation of the mammalian target of rapamycin complex 1 (mTORC1) causes the dissociation of eukaryotic initiation factor 4E complex (eIF4E)-binding protein 1 (4E-BP1) from eIF4E, leading to increased eIF4F complex formation. mTORC1 positively regulates protein synthesis and is implicated in several diseases including cardiac hypertrophy, a potentially fatal disorder involving increased cardiomyocyte size. The importance of 4E-BP1 in mTORC1-regulated protein synthesis was investigated by overexpressing 4E-BP1, which blocks eIF4F formation in isolated primary cardiomyocytes without affecting other targets for mTORC1 signaling. Interestingly, blocking eIF4F formation did not impair the degree of activation of overall protein synthesis by the hypertrophic agent phenylephrine (PE), which, furthermore, remained dependent on mTORC1. Overexpressing 4E-BP1 also only had a small effect on PE-induced cardiomyocyte growth. Overexpressing 4E-BP1 did diminish the PE-stimulated synthesis of luciferase encoded by structured mRNAs, confirming that such mRNAs do require eIF4F for their translation in cardiomyocytes. These data imply that the substantial inhibition of cardiomyocyte protein synthesis and growth caused by inhibiting mTORC1 cannot be attributed to the activation of 4E-BP1 or loss of eIF4F complexes. Our data indicate that increased eIF4F formation plays, at most, only a minor role in the mTORC1-dependent activation of overall protein synthesis in these primary cells but is required for the translation of structured mRNAs. Therefore, other mTORC1 targets are more important in the inhibition by rapamycin of the rapid activation of protein synthesis and of cell growth.
eukaryotic initiation factor 4E-binding protein 1, cardiac hypertrophy, mitochondrial ribonucleic acid translation, rapamycin
0363-6135
H505
Huang, Brandon P.H.
54f13bc3-0b06-4b29-89ed-de3733d3941b
Wang, Yanni
d9c1e6ce-1eaa-4ae7-a26a-07661b156b03
Wang, Xuemin
d6bb4eb2-5687-46ed-b770-cceb22fd792e
Wang, Zhuren
39be0603-27f7-4e49-9e23-b35062633ea9
Proud, Christopher G.
59dabfc8-4b44-4be8-a17f-578a58550cb3
Huang, Brandon P.H.
54f13bc3-0b06-4b29-89ed-de3733d3941b
Wang, Yanni
d9c1e6ce-1eaa-4ae7-a26a-07661b156b03
Wang, Xuemin
d6bb4eb2-5687-46ed-b770-cceb22fd792e
Wang, Zhuren
39be0603-27f7-4e49-9e23-b35062633ea9
Proud, Christopher G.
59dabfc8-4b44-4be8-a17f-578a58550cb3

Huang, Brandon P.H., Wang, Yanni, Wang, Xuemin, Wang, Zhuren and Proud, Christopher G. (2009) Blocking eukaryotic initiation factor 4F complex formation does not inhibit the mTORC1-dependent activation of protein synthesis in cardiomyocytes. American Journal of Physiology: Heart and Circulatory Physiology, 296 (2), H505. (doi:10.1152/ajpheart.01105.2008).

Record type: Article

Abstract

Activation of the mammalian target of rapamycin complex 1 (mTORC1) causes the dissociation of eukaryotic initiation factor 4E complex (eIF4E)-binding protein 1 (4E-BP1) from eIF4E, leading to increased eIF4F complex formation. mTORC1 positively regulates protein synthesis and is implicated in several diseases including cardiac hypertrophy, a potentially fatal disorder involving increased cardiomyocyte size. The importance of 4E-BP1 in mTORC1-regulated protein synthesis was investigated by overexpressing 4E-BP1, which blocks eIF4F formation in isolated primary cardiomyocytes without affecting other targets for mTORC1 signaling. Interestingly, blocking eIF4F formation did not impair the degree of activation of overall protein synthesis by the hypertrophic agent phenylephrine (PE), which, furthermore, remained dependent on mTORC1. Overexpressing 4E-BP1 also only had a small effect on PE-induced cardiomyocyte growth. Overexpressing 4E-BP1 did diminish the PE-stimulated synthesis of luciferase encoded by structured mRNAs, confirming that such mRNAs do require eIF4F for their translation in cardiomyocytes. These data imply that the substantial inhibition of cardiomyocyte protein synthesis and growth caused by inhibiting mTORC1 cannot be attributed to the activation of 4E-BP1 or loss of eIF4F complexes. Our data indicate that increased eIF4F formation plays, at most, only a minor role in the mTORC1-dependent activation of overall protein synthesis in these primary cells but is required for the translation of structured mRNAs. Therefore, other mTORC1 targets are more important in the inhibition by rapamycin of the rapid activation of protein synthesis and of cell growth.

This record has no associated files available for download.

More information

Published date: February 2009
Keywords: eukaryotic initiation factor 4E-binding protein 1, cardiac hypertrophy, mitochondrial ribonucleic acid translation, rapamycin

Identifiers

Local EPrints ID: 142725
URI: http://eprints.soton.ac.uk/id/eprint/142725
ISSN: 0363-6135
PURE UUID: 090da028-f459-48d7-a1e6-ce63be64f043

Catalogue record

Date deposited: 01 Apr 2010 15:53
Last modified: 14 Mar 2024 00:41

Export record

Altmetrics

Contributors

Author: Brandon P.H. Huang
Author: Yanni Wang
Author: Xuemin Wang
Author: Zhuren Wang
Author: Christopher G. Proud

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×